Automated vs manual medication adherence outreach
Manual adherence outreach is a person calling a patient to ask whether they are taking their medication. Automated outreach does the same contact by agent across the whole panel and flags the pattern rather than the call. Manual wins on relationship and on complex cases; automated wins on coverage, consistency and on noticing drift nobody had time to look for.
Adherence is a behaviour observed over weeks, which is a poor fit for an intervention rationed by someone’s calendar.
How do they compare, dimension by dimension?
Every row includes the detail the two icons cannot carry, including the rows where Manual outreach is the better option.
| Dimension | OneDose | Manual outreach | The honest detail |
|---|---|---|---|
| Whole-panel coverage | Manual outreach reaches the patients on someone’s list. The patients not on the list are not doing better — they are unobserved, and they are most of the panel. | ||
| Detecting drift across weeks | A missed evening dose pattern across three weeks is visible to a system watching continuously. It is very hard to see from two phone calls a quarter apart. | ||
| Building a relationship with the patient | A patient who knows their pharmacist by name and will tell them the truth about why they stopped is a real asset, and an agent does not replicate it. | ||
| Finding out why the patient stopped | The agent asks and records the reason. A trusted human often gets a more honest answer — cost and confusion are things people under-report to software. | ||
| Repeat contact attempts | The third attempt to reach someone is where manual outreach quietly stops, because a human’s time is better spent elsewhere. An agent’s is not. | ||
| Structured, comparable data | Manual outreach produces call notes. Call notes are not comparable across patients or across the person who wrote them. | ||
| Handling a complex psychosocial case | A patient not taking medication because of housing, money or family circumstances needs a person. An agent’s correct move is to escalate, which means a person does it anyway. | ||
| Cost at scale | Manual cost scales with the panel. This is the constraint that produces the rationing in the first place. |
What manual outreach gets right
Manual adherence outreach — a pharmacist, nurse or coordinator calling a patient — is the standard against which everything else is measured, and it is the standard for good reasons.
A human who has spoken to the same patient before gets a different answer than software does. "I stopped because it made me dizzy" is a thing people tell someone they trust. "I stopped because I could not afford the refill" is a thing people are embarrassed to tell anyone, and are more likely to admit to a person who is kind about it.
It also handles the cases where non-adherence is not really about medication — where the reason is money, housing, a family situation, or a patient who has decided they are done. Those need judgement and often need help that is not clinical at all.
When should you choose Manual outreach instead?
These are real cases, not throat-clearing. If one of them describes you, OneDose is the wrong purchase and a demo will waste both our time.
- The relationship is the intervention. For a small, complex, high-touch panel where the patient will tell a trusted person the truth, replacing that contact with an agent removes the mechanism that was working.
- Non-adherence is mostly psychosocial. If patients are stopping because of cost, housing or family circumstances rather than confusion or side-effects, they need a human who can actually act on that.
- The panel is small enough to genuinely cover. If a coordinator can reach every patient on the list at the cadence the care plan specifies, the coverage argument for automation does not apply to you.
- You have no way to act on what you find. Detecting drift across an entire panel produces escalations, and an organisation with nobody to receive them has bought a better view of a problem it still cannot fix.
When is OneDose the right choice?
- The panel is bigger than the team can contact at the cadence the care plan specifies — which is the normal case, not the exception.
- You need to know who is drifting, not just who called in. Drift is a pattern across weeks and is invisible from occasional contact.
- The reason a patient stopped needs to be captured as data rather than as a note, so it can be acted on and counted.
- The third and fourth contact attempts matter, and no human is going to make them.
Frequently asked
- Is automated medication adherence outreach better than manual outreach?
- They are good at different things. Automated outreach covers the whole panel, notices drift across weeks, makes the repeat attempts a human skips, and produces comparable data. Manual outreach gets more honest answers from patients who trust the caller and handles complex psychosocial non-adherence properly. On a small, high-touch, complex panel, manual is often the better choice.
- When is manual adherence outreach the right choice?
- When the panel is small enough to genuinely cover at the cadence the care plan specifies, when the relationship with the caller is itself the intervention, when non-adherence is mostly psychosocial rather than practical, or when there is nobody available to act on the escalations automation would generate.
- Can an agent find out why a patient stopped taking their medication?
- It asks and records the reason, and distinguishes a side-effect from a cost problem from confusion from a refill never collected. A trusted human often gets a more honest answer, particularly about cost, which patients under-report to software.